Published in Free Radic Biol Med on February 18, 2010
University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology. Curr Alzheimer Res (2012) 1.52
Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications. Antioxid Redox Signal (2012) 1.24
The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons. J Neuropathol Exp Neurol (2012) 1.09
Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease. Neurobiol Aging (2012) 1.04
Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain. Mech Ageing Dev (2011) 0.98
Amyloid-β toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer's disease. J Alzheimers Dis (2011) 0.98
Epigenetic changes in the progression of Alzheimer's disease. Mech Ageing Dev (2013) 0.97
DNA polymerase β deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes. Nucleic Acids Res (2014) 0.96
Formation of deoxyguanosine cross-links from calf thymus DNA treated with acrolein and 4-hydroxy-2-nonenal. Chem Res Toxicol (2010) 0.95
Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics. Neurobiol Dis (2010) 0.93
Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression. Neurobiol Aging (2010) 0.90
Chronic apocynin treatment attenuates beta amyloid plaque size and microglial number in hAPP(751)(SL) mice. PLoS One (2011) 0.90
Nucleic acid oxidation: an early feature of Alzheimer's disease. J Neurochem (2013) 0.88
High-fat diet induces changes in adipose tissue trans-4-oxo-2-nonenal and trans-4-hydroxy-2-nonenal levels in a depot-specific manner. Free Radic Biol Med (2013) 0.88
Oxidative damage and amyloid-β metabolism in brain regions of the longest-lived rodents. J Neurosci Res (2013) 0.86
Mass spectrometry-based quantification of myocardial protein adducts with acrolein in an in vivo model of oxidative stress. Mol Nutr Food Res (2011) 0.82
The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment. Free Radic Biol Med (2014) 0.81
Role of lipid peroxidation-derived α, β-unsaturated aldehydes in vascular dysfunction. Oxid Med Cell Longev (2013) 0.80
Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update. Arch Toxicol (2015) 0.79
4-Hydroxy-2-nonenal: a critical target in oxidative stress? Am J Physiol Cell Physiol (2016) 0.78
Acrolein Exposure in U.S. Tobacco Smokers and Non-Tobacco Users: NHANES 2005-2006. Environ Health Perspect (2015) 0.78
4-Hydroxy-2(E)-nonenal (HNE) catabolism and formation of HNE adducts are modulated by β oxidation of fatty acids in the isolated rat heart. Free Radic Biol Med (2013) 0.78
4-Hydroxyhexenal (HHE) impairs glutamate transport in astrocyte cultures. J Alzheimers Dis (2012) 0.75
Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target? Mech Ageing Dev (2016) 0.75
4-hydroxynonenal-mediated signaling and aging. Free Radic Biol Med (2016) 0.75
Exploring the Effect of Phyllanthus emblica L. on Cognitive Performance, Brain Antioxidant Markers and Acetylcholinesterase Activity in Rats: Promising Natural Gift for the Mitigation of Alzheimer's Disease. Ann Neurosci (2016) 0.75
4-Oxo-(E)-2-hexenal produced by Heteroptera induces permanent locomotive impairment in crickets that correlates with free thiol depletion. FEBS Open Bio (2015) 0.75
Acrolein acts as a neurotoxin in the nigrostriatal dopaminergic system of rat: involvement of α-synuclein aggregation and programmed cell death. Sci Rep (2017) 0.75
Signaling by 4-hydroxy-2-nonenal: Exposure protocols, target selectivity and degradation. Arch Biochem Biophys (2016) 0.75
Mitochondrial dysfunction in the APP/PSEN1 mouse model of Alzheimer's disease and a novel protective role for ascorbate. Free Radic Biol Med (2017) 0.75
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature (1986) 17.77
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med (1991) 16.01
Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol (2001) 4.80
4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res (2003) 4.41
"Preclinical" AD revisited: neuropathology of cognitively normal older adults. Neurology (2000) 3.57
RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci (1999) 2.86
Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem Phys Lipids (2008) 2.49
Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol (1994) 2.43
Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging (2001) 2.26
Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol Dis (2006) 2.04
Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J Biol Chem (1998) 2.02
Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging (1998) 1.91
Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids (1991) 1.90
Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain. J Neurochem (1999) 1.81
Ribosome dysfunction is an early event in Alzheimer's disease. J Neurosci (2005) 1.80
Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neurobiol Aging (2005) 1.60
Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem Res (1998) 1.57
Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment. J Neurochem (2006) 1.52
The identification and characterization of oxidized RNAs in Alzheimer's disease. J Neurosci (2003) 1.51
Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J Neurochem (1998) 1.50
Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis. Neurobiol Aging (2005) 1.50
Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann Neurol (2005) 1.49
Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J Neurochem (1999) 1.42
Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. Neurosci Lett (2006) 1.38
Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF. J Neurochem (1999) 1.27
Decreased base excision repair and increased helicase activity in Alzheimer's disease brain. Brain Res (2000) 1.26
Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease. Am J Pathol (2001) 1.26
Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde. QJM (2001) 1.24
Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer's disease. Neurochem Res (2006) 1.21
Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. Am J Pathol (1997) 1.16
Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer's disease brain. Free Radic Biol Med (2008) 1.10
Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology (1998) 1.09
Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetamine. J Pharmacol Exp Ther (2006) 1.07
Packing and viscoelasticity of polyunsaturated omega-3 and omega-6 lipid bilayers as seen by (2)H NMR and X-ray diffraction. J Am Chem Soc (2005) 1.03
Acrolein inhibits NADH-linked mitochondrial enzyme activity: implications for Alzheimer's disease. Neurotox Res (2003) 1.01
4-Hydroxynonenal oxidatively modifies histones: implications for Alzheimer's disease. Neurosci Lett (2004) 0.95
Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures. Free Radic Biol Med (2000) 0.93
4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau. Neuroreport (1997) 0.91
Formation of Nepsilon-(succinyl)lysine in vivo: a novel marker for docosahexaenoic acid-derived protein modification. J Lipid Res (2006) 0.86
Improved predictive model for pre-symptomatic mild cognitive impairment and Alzheimer's disease. Neurol Res (2008) 0.83
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA (1997) 10.75
A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med (1990) 7.92
Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA (1998) 6.49
Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. JAMA (1996) 4.40
Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci (1998) 4.19
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci U S A (1991) 3.85
"Preclinical" AD revisited: neuropathology of cognitively normal older adults. Neurology (2000) 3.57
Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol (1999) 3.20
Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res (1994) 3.02
Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study. Neurology (2002) 2.87
Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study. Am J Clin Nutr (2000) 2.54
Impaired proteasome function in Alzheimer's disease. J Neurochem (2000) 2.44
Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology (2005) 2.33
The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life. Neurology (2009) 2.33
Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging (2001) 2.26
Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology (1999) 2.16
Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. Neurology (2001) 2.15
Protein oxidation in the brain in Alzheimer's disease. Neuroscience (2001) 2.00
Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging (1998) 1.91
Host specificity of Salmonella infection in chickens and mice is expressed in vivo primarily at the level of the reticuloendothelial system. Infect Immun (1994) 1.91
Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J Neurochem (2005) 1.88
Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain. J Neurochem (1999) 1.81
Granular cell tumors of the central nervous system. J Neuropathol Exp Neurol (1973) 1.79
A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J Neurochem (1997) 1.79
The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. J Neurochem (2001) 1.75
Identification of Salmonella typhimurium genes required for colonization of the chicken alimentary tract and for virulence in newly hatched chicks. Infect Immun (1998) 1.73
Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem (1998) 1.71
Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid. Arch Neurol (2001) 1.68
Brain structural alterations before mild cognitive impairment. Neurology (2007) 1.66
Observations on the pathogenesis of experimental Salmonella typhimurium infection in chickens. Res Vet Sci (1987) 1.64
Bacteriophage therapy to reduce salmonella colonization of broiler chickens. Appl Environ Microbiol (2007) 1.64
Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci (1998) 1.63
Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J Neurol Sci (1996) 1.62
Treatment for patients with cerebral metastases. Arch Neurol (1978) 1.60
Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology (1995) 1.58
Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem Res (1998) 1.57
Hallervorden-Spatz disease and infantile neuroaxonal dystrophy. Ultrastructural observations, anatomical pathology and nosology. J Neurol Sci (1973) 1.55
Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J Neurochem (1995) 1.51
Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J Neurochem (1998) 1.50
p38 kinase is activated in the Alzheimer's disease brain. J Neurochem (1999) 1.50
Lipidized medulloblastoma in adults. Hum Pathol (1993) 1.50
The activity in the chicken alimentary tract of bacteriophages lytic for Salmonella typhimurium. Res Microbiol (1991) 1.49
Risk factors for transitions from normal to mild cognitive impairment and dementia. Neurology (2006) 1.46
Brain donation in normal aging: procedures, motivations, and donor characteristics from the Biologically Resilient Adults in Neurological Studies (BRAiNS) Project. Gerontologist (2001) 1.45
Possible involvement of proteasome inhibition in aging: implications for oxidative stress. Mech Ageing Dev (2000) 1.45
Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology (1988) 1.44
Contribution of Salmonella gallinarum large plasmid toward virulence in fowl typhoid. Infect Immun (1987) 1.41
Decreased levels of proteasome activity and proteasome expression in aging spinal cord. Neuroscience (2000) 1.40
Laser microprobe analysis of brain aluminum in Alzheimer's disease. Ann Neurol (1993) 1.39
Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol Aging (1991) 1.37
Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study. Alzheimer Dis Assoc Disord (2000) 1.36
Seven cases of cerebromedullospinal disconnection: the "locked-in" syndrome. Neurology (1971) 1.36
Suppression of essential tremor by propranolol: correlation of effect with drug plasma levels and intensity of beta-adrenergic blockade. Ann Neurol (1977) 1.36
Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol (1978) 1.33
Critical decline in fine motor hand movements in human aging. Neurology (1999) 1.32
Linguistic ability in early life and the neuropathology of Alzheimer's disease and cerebrovascular disease. Findings from the Nun Study. Ann N Y Acad Sci (2000) 1.31
Electron spin resonance study of membrane protein alterations in erythrocytes in Huntington's disease. Nature (1977) 1.28
Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF. J Neurochem (1999) 1.27
Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease. Am J Pathol (2001) 1.26
Decreased base excision repair and increased helicase activity in Alzheimer's disease brain. Brain Res (2000) 1.26
Invasion of Vero cells by Salmonella species. J Med Microbiol (1989) 1.26
White matter volumes and periventricular white matter hyperintensities in aging and dementia. Neurology (2000) 1.24
Late onset hereditary distal myopathy. Neurology (1974) 1.24
Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease. Ann Neurol (1998) 1.23
Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol Aging (1997) 1.23
Biopsy of human olfactory mucosa. An instrument and a technique. Arch Otolaryngol (1982) 1.23
The association between a large molecular mass plasmid and virulence in a strain of Salmonella pullorum. J Gen Microbiol (1988) 1.22
Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. Neurotoxicology (1998) 1.21
Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease. Neurobiol Aging (2008) 1.20
Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease. Neurosci Lett (2001) 1.19
Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies. Neurology (2009) 1.19
Memory complaints in nondemented men predict future pathologic diagnosis of Alzheimer disease. Neurology (2004) 1.19
Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann Neurol (1998) 1.18
Distal myopathy: electron microscopic and histochemical studies. Neurology (1977) 1.17
Delayed recall, hippocampal volume and Alzheimer neuropathology: findings from the Nun Study. Neurology (2004) 1.17
Lactic acidemia, mitochondrial myopathy, and basal ganglia calcification. Neurology (1979) 1.15
Comparison of neuropathologic criteria for the diagnosis of Alzheimer's disease. Neurobiol Aging (1997) 1.15
Experimental infection of egg-laying hens with Salmonella enteritidis phage type 4. Avian Pathol (1991) 1.13
Tau gene mutation in familial progressive subcortical gliosis. Nat Med (1999) 1.13
The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients. Am J Pathol (1999) 1.12
Survival of hippocampal and cortical neurons in a mixture of MEM+ and B27-supplemented neurobasal medium. Free Radic Biol Med (2000) 1.11
Oxidative modification of creatine kinase BB in Alzheimer's disease brain. J Neurochem (2000) 1.11
Histological features of congenital lipomas of the lower spinal canal. J Neurosurg (1980) 1.10
Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology (1998) 1.09
Escherichia coli resistant to tetracyclines and to other antibiotics in the faeces of U.K. chickens and pigs in 1980. J Hyg (Lond) (1981) 1.07
Brain trace element concentrations in aging. Neurobiol Aging (1984) 1.07
Methyl bromide intoxication: neurologic features, including simulation of Reye syndrome. Neurology (1977) 1.06
Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer's disease brain. Neuroscience (2006) 1.05
Contribution of proton-translocating proteins to the virulence of Salmonella enterica serovars Typhimurium, Gallinarum, and Dublin in chickens and mice. Infect Immun (2003) 1.04
Immunoglobulin and T cell receptor gene rearrangements in human lymphoma and leukemia. Blood (1987) 1.04
Intestinal colonisation in the chicken by food-poisoning Salmonella serotypes; microbial characteristics associated with faecal excretion. Avian Pathol (1988) 1.03
The fine structure of the olfactory mucosa in man. J Neurocytol (1982) 1.02